Genomic Valley Biotech Ltd is engaged in Horticulture businessBusiness Overview: Company conducts research in Biotechnology and does commercial production of Plant Tissue Cultured Plants of different species to feed genetically improved plant market nationally and internationally
Intimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026, pursuant to regulation 30 of SEBI (Listing ....
Genomic Valley Biotech Limited has announced the publication of its financial results for the quarter ended June 30, 2026. This update provides stakeholders with access to the company's latest performance data, enabling them to assess its operational health and financial standing for the recent quarter. It's a key transparency update...
Unaudited financial results for Quarter ended on 30 June 2026.
GVBL's Board has approved the financial results for the quarter ended June. This decision came from their recent meeting. Investors can now access the company's latest unaudited performance figures.
GVBL has announced a board meeting on August 14, 2026. The main agenda is to consider and approve the financial results for the quarter ended June 30, 2026.
